The Weekly Litigation News Digest is now live. Subscribe now

Hyaluronic Acid Based Formulations - EP2637710

The patent EP2637710 was granted to Allergan Industrie on Apr 5, 2017. The application was originally filed on Nov 8, 2011 under application number EP11799644A. The patent is currently recorded with a legal status of "Revoked".

EP2637710

ALLERGAN INDUSTRIE
Application Number
EP11799644A
Filing Date
Nov 8, 2011
Status
Revoked
Jan 26, 2024
Publication Date
Apr 5, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LABORATOIRES VIVACYJan 4, 2018TRIPOZADMISSIBLE
MERZ PHARMAJan 4, 2018WALLINGER RICKER SCHLOTTER TOSTMANNADMISSIBLE
FARCO PHARMADec 19, 2017VON ROHRADMISSIBLE
FARCO PHARMADec 19, 2017VON ROHR PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006194758
INTERNATIONAL-SEARCH-REPORTUS2006194758
INTERNATIONAL-SEARCH-REPORTUS2010028437
INTERNATIONAL-SEARCH-REPORTUS2010255068
INTERNATIONAL-SEARCH-REPORTWO2008068297
OPPOSITIONUS2003148995
OPPOSITIONUS2006194758
OPPOSITIONUS2010028437
OPPOSITIONUS2010255068
OPPOSITIONWO2004092222
OPPOSITIONWO2005067944
OPPOSITIONWO2005112888
OPPOSITIONWO2008068297
OPPOSITIONWO2010015901
OTHERUS2006194758

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents